Loading…
EndoArt, a subsidiary of BSS pharmaceutical holding, is launching a plant in St. Petersburg for cemented and cementless hip endoprostheses. The project required 1 billion rubles in investment, with capacity for up to 35,000 units annually. The plant is set to launch in August 2024.
| Site | Largest | Latest |
|---|---|---|
| St. Petersburg, Russia | $11.0M | 2024-07-31 |